Cornea/External Disease News

Sequential custom therapeutic keratectomy proved effective in the treatment of granular corneal dystrophy type 1, leading to long-term vision improvement and reduction of astigmatism and higher-order aberrations, according to a study.

Dry eye in thyroid eye disease appeared to primarily manifest as evaporative dry eye disease in a cohort of treatment-naive patients in China, according to study results published in Journal of Clinical Medicine.

Presurgical treatment with LipiFlow improved meibomian gland function in patients with range of vision IOLs, according to a study.

Contact lenses benefit patients with dry eye and ocular surface disease by providing visual rehabilitation, symptom relief and ocular surface protection, according to a review published in Indian Journal of Ophthalmology.

WASHINGTON — NOV03 met endpoints specific to ocular burning and itching as well as corneal staining in patients with dry eye at 57 days and 15 weeks, Ahmad M. Fahmy, OD, FAAO, Dipl ABO, said in this Healio video from Optometry’s Meeting.

An affiliate of Bausch + Lomb acquired the over-the-counter Blink product line of eye and contact lens drops from Johnson & Johnson Vision, according to a press release.

Healio’s top ophthalmology items this week covered the accuracy of self-administered eye drops and the efficacy of thickening corneas before cross-linking.

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Zeba A. Syed, MD, ABO, discusses a study that evaluated the thickening of corneas before corneal cross-linking.

In this Healio Video Perspective from the ASCRS meeting, Jeff Wongs, MD, discusses a study that investigated the benefits of cryopreserved amniotic membrane to restore the ocular surface to a healthy state.

Novartis has entered a transaction of up to $2.5 billion to divest ‘front of eye’ ophthalmology assets, including Xiidra, to Bausch + Lomb, according to a company press release.